Virpax 50 Mg is a muco-adhesivebuccogingival treatment indicated for recurrent herpes labialis. Discover its benefits and how to use it today!
Virpax 50 Mg is your ally against recurrent herpes labialis. Find out how this innovative treatment can help relieve unpleasant symptoms and reduce the frequency of outbreaks.
Cold sores, commonly known as fever blisters, are a common viral infection caused by the herpes simplex virus type 1 (HSV-1). The condition is characterized by the appearance of small, fluid-filled blisters, often painful and sometimes itchy, on or around the lips. However, it should be noted that herpes labialis can also affect other areas of the face, such as the nose or cheeks.
Herpes labialis outbreaks usually occur following a variety of triggers, including stress, excessive sun exposure, a lowered immune system due to illness or medical treatment, and menstruation in women. These factors can activate the latent virus and trigger a recurrence of symptoms.
Although herpes labialis is not generally considered a serious health threat, it can cause significant discomfort for those affected. Painful blisters can make everyday activities such as eating, drinking and talking uncomfortable. What's more, cold sore outbreaks can have a negative impact on people's self-esteem and self-confidence, due to the visible appearance of the lesions.
Prompt treatment of cold sore outbreaks is crucial to relieve symptoms and speed up the healing process. Antiviral medications, such as Virpax 50 Mg, can be prescribed to reduce the duration and severity of outbreaks, as well as to prevent recurrences. In addition, hygiene measures such as using antiviral creams, maintaining good oral hygiene and sun protection can help reduce the risk of spreading the virus to other parts of the body or to other people.
In summary, although cold sores can be a source of discomfort and embarrassment, it is possible to effectively manage symptoms and prevent recurrences through appropriate treatment and preventive measures. It is therefore important for sufferers to consult a healthcare professional as soon as the first signs of a cold sore outbreak appear, in order to obtain appropriate treatment and reduce the impact of this condition on their quality of life.
Thanks to its active ingredient,aciclovir, Virpax acts directly on the herpes virus, inhibiting its replication and reducing the duration and severity of outbreaks. Its muco-adhesive buccogingival administration ensures a gradual release of aciclovir, offering prolonged relief.
We also offer Boiron Labiaméo Poussées Herpès Labial 3 tubes granules, at the best price in our online pharmacy.
Use as recommended in the leaflet or on the advice of a healthcare professional. Apply a single tablet to the gums, once a day, only during a cold sore episode. Treatment should begin within one hour of the appearance of the first signs (tingling, burning, itching).
Do not swallow, suck or chew the tablet. Place the rounded side against the gum, preferably over an incisor or inside the lip. Apply pressure with a clean finger to the outer lip for 30 seconds to ensure adhesion. The tablet melts slowly over the course of the day, releasing aciclovir over a long period.
If the tablet falls out within the first six hours, apply a new one. After six hours, do not replace the tablet. If accidentally swallowed, drink a glass of water. If ingestion occurs within the first six hours, a new tablet may be applied (once only).
Do not brush your teeth, chew gum or touch the tablet during treatment.
Give your opinion on the advice for use and dosage of Virpax 50 Mg 1 Comprimé Buccogingival with our partner Avis Vérifiés after your purchase.
Precautions for use
Ingredients:
Each tablet contains 50 mg aciclovir.
Excipient: lactose (lactose residues derived from milk protein concentrate), sodium laurilsulfate.
Packaging:
Box of 1 tablet. Available at the best price from our online pharmacy.
Herpes labialis outbreaks can become a real handicap in everyday life, both physically and emotionally. The advantage of a muco-adhesive tablet such as Virpax lies in its localized, prolonged action, which means it can be used as soon as the first signs appear, without interrupting daily activities. In pharmacies, this format is attractive for its practicality and discretion. What's more, it's part of a growing trend to limit systemic treatments in favor of targeted topical solutions. Some customers also make it part of a more global strategy, adopting a healthy lifestyle to prevent recurrences.
When should Virpax 50 mg be applied?
This tablet should be used within one hour of the first signs of a fever blister to ensure optimum efficacy.
Can I eat or drink with the tablet in place?
Yes, once the tablet is properly attached to the gums, you can eat and drink without interfering with its action.
Can Virpax be used in children?
No, this drug is reserved for immunocompetent adults over 18 years of age.
Pharmacovigilance Report an adverse drug reaction(s)
NOTICE
ANSM - Updated on : 27/11/2023
Product name
VIRPAX 50 mg, muco-adhesive buccogingival tablet
acyclovir
Box
Please read this leaflet carefully before using this medicine, as it contains important information for you.
You must always use this medicine in strict accordance with the information given in this leaflet or by your doctor, pharmacist or nurse.
- Keep this leaflet. You may need to read it again.
- Ask your pharmacist for advice and information.
- If you experience any side effects, talk to your doctor, pharmacist or nurse. This also applies to any side effects not mentioned in this leaflet. See section 4.
- You should contact your doctor if you do not feel any improvement or if you feel less well after 5 days.
What does this leaflet contain?
1. What is VIRPAX 50 mg, muco-adhesive buccogingival tablet and what is it used for?
2. What do I need to know before using VIRPAX 50 mg, buccogingival mucoadhesive tablet?
3. How do I use VIRPAX 50 mg, buccogingival mucoadhesive tablet?
4. What are the possible side effects?
5. How to store VIRPAX 50 mg, buccogingival mucoadhesive tablet?
6. Package contents and other information.
1. WHAT IS VIRPAX 50 mg, buccogingival mucoadhesive tablet AND WHAT IS IT USED FOR?
Pharmacotherapeutic class - ATC code: Anti-viral for local treatment - J05AB01.
Virpax contains the active substance aciclovir and belongs to a group of medicines known as antivirals.
Virpax is used to treat recurrent cold sores caused by the herpes simplex virus in adults with a functioning immune system. Virpax should be applied directly to the gums as soon as the first symptoms (burning, tingling, itching) or signs (redness, swelling) appear.
The virus causes vesicles or inflammation mainly on the lips, but sometimes also on other parts of the face. This viral infection can be activated when the immune system is weakened, for example by colds or other infections. Heavy sun exposure, stress or menstruation can also trigger symptoms.
Virpax inhibits the virus' ability to reproduce, allowing the infection to regress.
You should contact your doctor if you feel no improvement or if symptoms do not diminish after 5 days.
2. WHAT DO I NEED TO KNOW BEFORE USING VIRPAX?
Never use VIRPAX 50 mg, muco-adhesive buccogingival tablet :
- if you are allergic (hypersensitive) to aciclovir or to any of the other ingredients of this medicine (listed in section 6);
- if you are allergic to milk or milk derivatives.
Warnings and precautions
- Virpax may be accidentally swallowed. If Virpax is accidentally swallowed, it is recommended that you drink a glass of water.
- Talk to your doctor before using this medicine if your immune system is weakened (in connection with another disease affecting the immune system, e.g. AIDS or organ transplantation) or because of treatment affecting your immune system (e.g. immunosuppressive drugs). Virpax should not be taken in these cases, as it has never been used in patients with weakened immune systems (immunocompromised patients).
- We do not know whether Virpax works if used after the appearance of blisters or inflammation. Therefore, use Virpax only when you experience the first symptoms of cold sores (itching, redness or tingling).
Children and adolescents
This medicine must not be used in children and adolescents under 18 years of age.
Other medicines and VIRPAX 50 mg, muco-adhesive buccogingival tablet
Tell your doctor or pharmacist if you are taking, have recently taken or may take any other medicines.
VIRPAX 50 mg, buccogingival mucoadhesive tablet with food and drink
You can eat and drink normally once VIRPAX is in place.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to become pregnant, ask your doctor or pharmacist for advice before taking this medicine.
Virpax may be used during pregnancy and lactation.
Driving and using machines
This medicine has no effect on the ability to drive vehicles or use machines.
VIRPAX 50 mg, buccogingival mucoadhesive tablet contains milk protein concentrate with traces of lactose and sodium lauryl sulfate.
This medicine contains 5.2 mg sodium laurilsulfate per tablet.
Sodium laurilsulfate may cause local skin reactions (such as a stinging or burning sensation) or increase skin reactions caused by other products when applied to the same area.
If your doctor has informed you that you are intolerant to certain sugars (lactose, etc.), contact him/her before taking this medicine.
3. HOW SHOULD VIRPAX BE TAKEN?
Always use this medicine exactly as instructed in the package leaflet or by your doctor or pharmacist. Check with your doctor or pharmacist if in doubt.
Recommended dose :
One tablet to be stuck on the gum per coldsore episode.
DO NOT SWALLOW TABLET
If accidentally swallowed, drink a glass of water.
Instructions for proper use
This medication should be applied to the upper gums (just above the incisor) as soon as the first symptoms or signs of cold sores appear (itching, redness or tingling):
- Before applying the tablet, locate where the tablet is to be applied to the upper gum above an incisor.
- You'll notice that the tablet has a rounded face and a flat face engraved with "AL21". Apply the tablet with a dry finger immediately after removing it from the blister pack.
- For comfort, whichever side of the lip the first signs or symptoms appear on, place the rounded side against the gum. The tablet can be stuck to either side.
- To make sure the tablet adheres properly to the gum, press your finger on the outside of your upper lip for 30 seconds, without pressing directly on the tablet.
- If your mouth is dry, drink water to moisten your gums before applying the tablet. The tablet can also be applied to the inside of the lip rather than against the gum.
Once applied, the tablet stays in place and gradually dissolves over the course of the day.
Once applied, do not suck, chew or swallow the tablet.
All situations that may interfere with the tablet's adhesion should be avoided:
- Touching or pressing on the tablet already in place.
- Chewing gum.
- Brushing your teeth while the tablet is in place.
If this medication does not adhere or falls out within the first 6 hours, the same tablet should be reinserted immediately. If the tablet cannot be reinserted, a new tablet must be applied.
If you accidentally swallow a Virpax tablet, drink a glass of water.
If the tablet is dropped or swallowed within the first 6 hours after application, it should be replaced only once.
If the tablet is accidentally dropped or swallowed after 6 hours, it should not be replaced.
If you have taken more VIRPAX 50 mg, muco-adhesive buccogingival tablet, than you should have: Consult your doctor or pharmacist immediately, even if the risk of overdosage is low, given the low absorption into the blood after taking Virpax.
View instructions for administration and special recommendations on :
Domain name/link being created for access to the ANSM-approved video.
4. WHAT ARE THE POSSIBLE SIDE EFFECTS?
Like all medicines, this drug may cause undesirable effects, but they do not occur systematically in everyone.
Common side effects (may affect up to 1 in 10 people):
- Headache
- Pain at application site
Uncommon side effects (which may affect up to 1 in 100 people):
- Dizziness
- nausea
- Irritation at application site
- Aphta
- Gingival pain
- Redness
Reporting side effects
If you experience any side effects, please tell your doctor, pharmacist or nurse. This also applies to any side effects not mentioned in this leaflet. You can also report adverse reactions directly via the national reporting system: Agence nationale de sécurité du médicament et des produits de santé (ANSM) and the network of Centres Régionaux de Pharmacovigilance - Website: https://signalement.social-sante.gouv.fr
By reporting adverse reactions, you contribute to providing more information on drug safety.
5. HOW TO CONSERVE VIRPAX 50 mg, muco-adhesive buccogingival tablet?
Keep out of sight and reach of children.
Do not use this medicine after the expiration date indicated on the packaging and blister after "EXP". The expiration date refers to the last day of that month.
Store at a temperature not exceeding 30°C.
Do not dispose of any medicine down the drain or in the household waste. Ask your pharmacist to dispose of any medicines you no longer use. These measures will help protect the environment.
6. CONTENTS AND OTHER INFORMATION
What VIRPAX 50 mg buccogingival mucoadhesive tablet contains
- The active substance is laciclovir. Each mucoadhesive buccogingival tablet contains 50 mg of laciclovir.
- Other ingredients: hypromellose, milk protein concentrate with traces of lactose, sodium lauryl sulfate, magnesium stearate, microcrystalline cellulose, povidone, colloidal anhydrous silica.
What VIRPAX 50 mg, muco-adhesive buccogingival tablet is and what it contains
This medicine is a white to yellowish, 8 mm muco-adhesive buccogingival tablet with a rounded face and a flat face marked "AL21".
Each box of Virpax contains 1 or 2 unit blister(s) of 1 tablet.
Marketing authorization holder
VECTANS PHARMA
230 BUREAUX DE LA COLLINE
92213 SAINT-CLOUD CEDEX
Marketing authorization holder
ZAMBON FRANCE S.A.
13 RUE RENE JACQUES,
92130 ISSY-LES-MOULINEAUX
Manufacturer
FARMEA
10 RUE BOUCHE THOMAS
ZAC DORGEMONT
49000 ANGERS CEDEX
Product names in member states of the European Economic Area
This medicinal product is authorized in the member states of the European Economic Area under the following names: In accordance with current regulations.
[To be completed subsequently by the holder].
The last date on which this leaflet was revised was :
[to be completed later by the holder]
< {MM/YYYY}>< {month/YYYY}.>
Other
Detailed information on this drug is available on the ANSM (France) website.
Health education advice :
Cold sores or herpes labialis are due to an infection caused by a virus called Herpes simplex. After a primary infection, the virus persists in the body without causing any symptoms.
The virus can sometimes be reactivated by events such as fatigue, menstruation, fever, emotion or exposure to the sun.reactivated, leading to the appearance of clusters of vesicles (blisters) around the lips, known as fever blisters. These vesicles are contagious until scabs appear, a sign of healing.
There are localized warning signs at the usual site of the lesion, usually a burning and/or tingling sensation.
These signs are important to know:
- treatment must be started as soon as they appear, to prevent viral multiplication and limit the development of fever blisters,
- It's also as soon as they appear that you should observe the following rules of hygiene to reduce the risk of transmitting the virus to yourself and those around you.
- Avoid close contact, such as kissing, with those around you.
- NEVER KISS AN INFANT.
- Wash your hands thoroughly after any contact with the lesion.
- During treatment, to avoid spreading the lesions, never rub your eyes or eyelids with your hands, and if you wear contact lenses, never moisten them with your saliva.
- Avoid touching or scratching the lesions.
Never use VIRPAX on any other part of your herpes outbreak, TAKE YOUR DOCTOR'S ADVICE.
On the other hand, aciclovir cannot act on viruses that persist in a latent state in the body, and aciclovir does not prevent recurrences after treatment has been discontinued.
Antiviral
.Présentations. Composition.Indications.Attention.Grossesse et allaitement.Mode d'emploi et posologie. Conseils.Effets indésirables.Lexique
VIRPAX 50 mg : comprimé buccogingival (blanc) ; boîte de 1.
Non remboursé - Prix libre -
Laboratoire Zambon France
| p cp | |
| Aciclovir | 50 mg |
| Lactose | + |
Posologie usuelle:
The figures are astonishing: 9 million French people develop cold sores each year! Depending on the country, 50 to 90% of the population is infected with this virus! By the age of 4, 75% of children have already been in contact with this highly contagious virus. What is herpes? Herpes labialis or cold sore is a benign condition for the majority of people that we would…
Read the article on the blogHerpes labialis, also known as a cold sore, is a recurrent viral infection caused by the herpes simplex virus type 1 (HSV-1). Once contracted, this virus remains in the body for life and can be reactivated by stress, fatigue, exposure to sunlight or a weakened immune system. While no treatment can eliminate the virus once and for all, there are…
Read the article on the blogIn homeopathy, dosage is not based on the dose of the active substance, but on its dilution, frequency of administration and relevance to the symptoms observed. In infants, this precision is even more important, as their bodies react in subtle ways. So it's not a question of taking too many doses, but of choosing the right remedy, at the right…
Read the article on the blog
